Personal information

No personal information available

Activities

Collapse all

Employment (1)

Memorial Sloan Kettering Cancer Center: New York, New York, US

Assistant Attending (Sarcoma Medical Oncology/Immunotherapeutics Core)
Employment
Source: Self-asserted source
Sandra P. D'Angelo

Works (12)

Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma

Journal of Clinical Oncology
2025-01-21 | Journal article
DOI: 10.1200/JCO-24-01466
Contributors: Sandra P. D'Angelo; Mihaela Druta; Brian A. Van Tine; David Liebner; Scott M. Schuetze; William D. Tap; Jessica Preston; Sophia Goodison; Jimson W. D'Souza; Gurpreet S. Kapoor et al.
Source: check_circle
Crossref

Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma

Clinical Cancer Research
2024-10-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-0395
Contributors: Sandra P. D’Angelo; Céleste Lebbé; Paul Nghiem; Andrew S. Brohl; Thomas Mrowiec; Trent Leslie; Sara Georges; Gülseren Güzel; Parantu Shah
Source: check_circle
Crossref

Data from Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma

2024-10-01 | Preprint
DOI: 10.1158/1078-0432.c.7474429
Contributors: Sandra P. D’Angelo; Céleste Lebbé; Paul Nghiem; Andrew S. Brohl; Thomas Mrowiec; Trent Leslie; Sara Georges; Gülseren Güzel; Parantu Shah
Source: check_circle
Crossref

Supplementary Data 1 from Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma

2024-10-01 | Preprint
DOI: 10.1158/1078-0432.27142171
Contributors: Sandra P. D’Angelo; Céleste Lebbé; Paul Nghiem; Andrew S. Brohl; Thomas Mrowiec; Trent Leslie; Sara Georges; Gülseren Güzel; Parantu Shah
Source: check_circle
Crossref

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

Nature Communications
2022-06-16 | Journal article
DOI: 10.1038/s41467-022-30874-8
Contributors: Sandra P. D’Angelo; Allison L. Richards; Anthony P. Conley; Hyung Jun Woo; Mark A. Dickson; Mrinal Gounder; Ciara Kelly; Mary Louise Keohan; Sujana Movva; Katherine Thornton et al.
Source: check_circle
Crossref

Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor

Journal of Clinical Oncology
2022-03-20 | Journal article
DOI: 10.1200/JCO.21.02029
Contributors: Ping Chi; Li-Xuan Qin; Bastien Nguyen; Ciara M. Kelly; Sandra P. D'Angelo; Mark A. Dickson; Mrinal M. Gounder; Mary L. Keohan; Sujana Movva; Benjamin A. Nacev et al.
Source: check_circle
Crossref

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

Journal for ImmunoTherapy of Cancer
2022-02 | Journal article
DOI: 10.1136/jitc-2021-003302
Contributors: Juliane Manitz; Sandra P D'Angelo; Andrea B Apolo; S Peter Eggleton; Marcis Bajars; Oliver Bohnsack; James L Gulley
Source: check_circle
Crossref

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study

Journal for ImmunoTherapy of Cancer
2021-07 | Journal article
DOI: 10.1136/jitc-2021-002646
Contributors: Sandra P D'Angelo; Celeste Lebbé; Laurent Mortier; Andrew S Brohl; Nicola Fazio; Jean-Jacques Grob; Natalie Prinzi; Glenn J Hanna; Jessica C Hassel; Felix Kiecker et al.
Source: check_circle
Crossref

Efficacy and immune-related adverse event associations in avelumab-treated patients

Journal for ImmunoTherapy of Cancer
2020-11 | Journal article
DOI: 10.1136/jitc-2020-001427
Contributors: Karen Kelly; Juliane Manitz; Manish R Patel; Sandra P D’Angelo; Andrea B Apolo; Arun Rajan; Vijay Kasturi; Isabell Speit; Marcis Bajars; John Warth et al.
Source: check_circle
Crossref

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Journal for ImmunoTherapy of Cancer
2020-05 | Journal article
DOI: 10.1136/jitc-2020-000674
Contributors: Sandra P D'Angelo; Shailender Bhatia; Andrew S Brohl; Omid Hamid; Janice M Mehnert; Patrick Terheyden; Kent C Shih; Isaac Brownell; Celeste Lebbé; Karl D Lewis et al.
Source: check_circle
Crossref

Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients

Sarcoma
2020-02-15 | Journal article
DOI: 10.1155/2020/3852420
Contributors: Charles Sutton; Yachao Zhang; DaeHee Kim; Hooman Yarmohammadi; Etay Ziv; Franz E. Boas; Constantinos T. Sofocleous; William D. Tap; Sandra P. D’Angelo; Joseph P. Erinjeri
Source: check_circle
Crossref

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Human Pathology
2015-03 | Journal article
DOI: 10.1016/j.humpath.2014.11.001
Contributors: Sandra P. D’Angelo; Alexander N. Shoushtari; Narasimhan P. Agaram; Deborah Kuk; Li-Xuan Qin; Richard D. Carvajal; Mark A. Dickson; Mrinal Gounder; Mary Louise Keohan; Gary K. Schwartz et al.
Source: check_circle
Crossref
How many people are using ORCID?